{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:53:17Z","timestamp":1782604397484,"version":"3.54.5"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,15]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Gitelman syndrome (GS) is an uncommon autosomal recessive tubulopathy resulting from a functional deletion mutation in the SLC12A3 gene. Its onset is typically insidious and challenging to discern, and it is characterized by hypokalemia, metabolic alkalosis, and reduced urinary calcium excretion. There is limited literature on the diagnosis and management of GS in individuals with concomitant diabetes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 36-year-old male patient with a longstanding history of diabetes exhibited suboptimal glycemic control. Additionally, he presented with concurrent findings of hypokalemia, hypomagnesemia, hypocalciuria, and metabolic alkalosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Building upon the patient\u2019s clinical manifestations and extensive laboratory evaluations, we conducted thorough genetic testing, leading to the identification of a compound heterozygous mutation within the SLC12A3 gene. This definitive finding confirmed the diagnosis of GS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>We have formulated a detailed medication regimen for patients, encompassing personalized selection of hypoglycemic medications and targeted electrolyte supplementation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Following 1 week of comprehensive therapeutic intervention, the patient\u2019s serum potassium level effectively normalized to 3.79 mmol\/L, blood glucose parameters stabilized, and there was significant alleviation of clinical symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>GS has a hidden onset and requires early diagnosis and intervention based on patient related symptoms and laboratory indicators in clinical practice, and personalized medication plans need to be provided according to the specific situation of the patient.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000036663","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T21:15:37Z","timestamp":1702674937000},"page":"e36663","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Gitelman syndrome combined with diabetes mellitus: A case report and literature review"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3487-9905","authenticated-orcid":false,"given":"Xiaoyan","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaohui","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Fujian Medical University, Quanzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunpan","family":"Mou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjia","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","first-page":"902","article-title":"Chinese Research Hospital Society Rare Disease Branch, Chinese Rare Disease Alliance, Beijing Rare Disease Diagnosis Treatment and Support Society, Chinese Expert Group on Gitelman Syndrome Chinese Expert Consensus on Diagnosis and Treatment of Gitelman Syndrome (2021 edition).","volume":"12","author":"Zhang","year":"2021","journal-title":"Med J Peking Union Med College Hosp"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pcl.2018.08.010","article-title":"Bartter syndrome and Gitelman syndrome.","volume":"66","author":"Fulchiero","year":"2019","journal-title":"Pediatr Clin North Am"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12887-019-1498-3","article-title":"Digenetic inheritance of SLC12A3 and CLCNKB genes in a Chinese girl with Gitelman syndrome.","volume":"19","author":"Kong","year":"2019","journal-title":"BMC Pediatr"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4081\/reumatismo.2020.1255","article-title":"Gitelman syndrome associated with chondrocalcinosis and severe neuropathy: a novel heterozygous mutation in SLC12A3 gene.","volume":"72","author":"Conticini","year":"2020","journal-title":"Reumatismo"},{"key":"R6-20250504","first-page":"279389","article-title":"Gitelman syndrome in a school boy who presented with generalized convulsion and had a R642H\/R642W mutation in the SLC12A3 gene.","volume":"2014","author":"Makino","year":"2014","journal-title":"Case Rep Pediatr"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e16408","DOI":"10.1097\/MD.0000000000016408","article-title":"Gitelman\u2019s syndrome with hyperphosphatemia, effectively responding to single oral magnesium oxide administration: a case report.","volume":"98","author":"Miya","year":"2019","journal-title":"Medicine (Baltim)"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12882-023-03180-8","article-title":"Gitelman syndrome with Graves\u2019 disease leading to rhabdomyolysis: a case report and literature review.","volume":"24","author":"Xu","year":"2023","journal-title":"BMC Nephrol"},{"key":"R9-20250504","first-page":"e33565","article-title":"Cardiac arrest as the first presentation of Gitelman syndrome.","volume":"15","author":"Geletu","year":"2023","journal-title":"Cureus"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1046\/j.1523-1755.2001.059002710.x","article-title":"Gitelman\u2019s syndrome revisited: an evaluation of symptoms and health-related quality of life.","volume":"59","author":"Cruz","year":"2001","journal-title":"Kidney Int"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"11414","DOI":"10.3390\/ijms222111414","article-title":"molecular basis, diagnostic challenges and therapeutic approaches of bartter and gitelman syndromes: a primer for clinicians.","volume":"22","author":"Nunez-Gonzalez","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11255-017-1653-4","article-title":"Gitelman syndrome: an analysis of the underlying pathophysiologic mechanisms of acid-base and electrolyte abnormalities.","volume":"50","author":"Filippatos","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/cen.14104","article-title":"The challenges of diagnosis and management of Gitelman syndrome.","volume":"92","author":"Urwin","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1681\/ASN.2021050596","article-title":"Gitelman-like syndrome caused by pathogenic variants in mtDNA.","volume":"33","author":"Viering","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"R15-20250504","first-page":"794","article-title":"mtDNA variants in Gitelman-like syndrome.","volume":"17","author":"Allison","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/ndt\/gfy199","article-title":"Liquorice, Liddle, Bartter or Gitelman-how to differentiate?","volume":"34","author":"Mumford","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/MOP.0000000000000447","article-title":"Bartter\u2019s and Gitelman\u2019s syndrome.","volume":"29","author":"Seyberth","year":"2017","journal-title":"Curr Opin Pediatr"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.kint.2020.10.035","article-title":"Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for tubular disorders.","volume":"99","author":"Konrad","year":"2021","journal-title":"Kidney Int"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"bvac079","DOI":"10.1210\/jendso\/bvac079","article-title":"The Bartter-Gitelman spectrum: 50-year follow-up with revision of diagnosis after whole-genome sequencing.","volume":"6","author":"Stevenson","year":"2022","journal-title":"J Endocr Soc"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000448694","article-title":"Genotype\/phenotype analysis in 67 Chinese patients with Gitelman\u2019s syndrome.","volume":"44","author":"Liu","year":"2016","journal-title":"Am J Nephrol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1530\/EC-17-0014","article-title":"Glucose tolerance and insulin responsiveness in Gitelman syndrome patients.","volume":"6","author":"Yuan","year":"2017","journal-title":"Endocr Connect"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1681\/ASN.2019010031","article-title":"Resistance to insulin in patients with Gitelman syndrome and a subtle intermediate phenotype in heterozygous carriers: a cross-sectional study.","volume":"30","author":"Blanchard","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"R24-20250504","first-page":"321","article-title":"A rare case of hypokalemia-induced rhabdomyolysis.","volume":"15","author":"He","year":"2018","journal-title":"J Geriatr Cardiol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"E1478","DOI":"10.1210\/jc.2012-1707","article-title":"Genotype, phenotype, and follow-up in Taiwanese patients with salt-losing tubulopathy associated with SLC12A3 mutation.","volume":"97","author":"Tseng","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/HYPERTENSIONAHA.108.119438","article-title":"Changes in serum potassium mediate thiazide-induced diabetes.","volume":"52","author":"Shafi","year":"2008","journal-title":"Hypertension"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMe068142","article-title":"ATP-sensitive potassium channels\u2013neonatal diabetes mellitus and beyond.","volume":"355","author":"Sperling","year":"2006","journal-title":"N Engl J Med"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.abb.2006.05.007","article-title":"Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance.","volume":"458","author":"Barbagallo","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2362.2008.01957.x","article-title":"Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study.","volume":"38","author":"Guerrero-Romero","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"R30-20250504","first-page":"1090","article-title":"A systematic review of the role of renin angiotensin aldosterone system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy.","volume":"19","author":"Rahimi","year":"2014","journal-title":"J Res Med Sci"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fendo.2020.00178","article-title":"GLP-1 analogs and DPP-4 inhibitors in type 2 diabetes therapy: review of head-to-head clinical trials.","volume":"11","author":"Gilbert","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"8954","DOI":"10.3390\/ijms23168954","article-title":"Mineralocorticoid receptor activation in vascular insulin resistance and dysfunction.","volume":"23","author":"Igbekele","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.119.13922","article-title":"Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans.","volume":"75","author":"Adler","year":"2020","journal-title":"Hypertension"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"R276","DOI":"10.1152\/ajpregu.00280.2020","article-title":"Mineralocorticoid receptors in the pathogenesis of insulin resistance and related disorders: from basic studies to clinical disease.","volume":"320","author":"Jia","year":"2021","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc09-9032","article-title":"Hyperglycemic crises in adult patients with diabetes.","volume":"32","author":"Kitabchi","year":"2009","journal-title":"Diabetes Care"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.kint.2016.09.046","article-title":"Gitelman syndrome: consensus and guidance from a kidney disease: improving global outcomes (KDIGO) controversies conference.","volume":"91","author":"Blanchard","year":"2017","journal-title":"Kidney Int"},{"key":"R38-20250504","first-page":"508","article-title":"Magnesium lactate in the treatment of Gitelman syndrome: patient-reported outcomes.","volume":"32","author":"Robinson","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00467-010-1575-1","article-title":"Early appearance of hypokalemia in Gitelman syndrome.","volume":"25","author":"Tammaro","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10157-016-1284-6","article-title":"Mutation profile and treatment of Gitelman syndrome in Chinese patients.","volume":"21","author":"Wang","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5414\/CNP58073","article-title":"Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman\u2019s syndrome.","volume":"58","author":"Mayan","year":"2002","journal-title":"Clin Nephrol"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/ckj\/sfu029","article-title":"A severe phenotype of Gitelman syndrome with increased prostaglandin excretion and favorable response to indomethacin.","volume":"7","author":"Larkins","year":"2014","journal-title":"Clin Kidney J"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1681\/ASN.2014030293","article-title":"Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome.","volume":"26","author":"Blanchard","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40618-015-0371-y","article-title":"A novel SLC12A3 gene homozygous mutation of Gitelman syndrome in an Asian pedigree and literature review.","volume":"39","author":"Lu","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/nep.13743","article-title":"Clinical and laboratory features of female Gitelman syndrome and the pregnancy outcomes in a Chinese cohort.","volume":"25","author":"Zhang","year":"2020","journal-title":"Nephrology (Carlton)"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"799224","DOI":"10.3389\/fgene.2022.799224","article-title":"Genetic and biological effects of SLC12A3, a Sodium-Chloride cotransporter, in Gitelman syndrome and diabetic kidney disease.","volume":"13","author":"Li","year":"2022","journal-title":"Front Genet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036663","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:14:08Z","timestamp":1746321248000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":44,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036663","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]}}}